Effect of Grapefruit Juice and Ritonavir on Pharmacokinetics of Lopinavir in Wistar Rats

Lopinavir (LPV), a newer HIV protease inhibitor, has poor bioavailability being a substrate of both cytochrome P450 3A enzyme system (CYP3A) and permeability‐glycoprotein (P‐gp). Ritonavir (RTV) is a known inhibitor of both P‐gp and CYP3A and is co‐administered with LPV in anti‐HIV therapy. Grapefru...

Full description

Saved in:
Bibliographic Details
Published in:Phytotherapy research Vol. 26; no. 10; pp. 1490 - 1495
Main Authors: Ravi, P. R., Vats, R., Thakur, R., Srivani, S., Aditya, N.
Format: Journal Article
Language:English
Published: Chichester Blackwell Publishing Ltd 01-10-2012
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Lopinavir (LPV), a newer HIV protease inhibitor, has poor bioavailability being a substrate of both cytochrome P450 3A enzyme system (CYP3A) and permeability‐glycoprotein (P‐gp). Ritonavir (RTV) is a known inhibitor of both P‐gp and CYP3A and is co‐administered with LPV in anti‐HIV therapy. Grapefruit juice (GFJ) is known to inhibit CYP3A and has conflicting effects, ranging from activation to inhibition, on P‐gp. In this research work, the effects of GFJ and RTV on the pharmacokinetics of LPV were compared in rats. A mechanistic evaluation was undertaken using various in vitro and ex vivo studies to support the in vivo pharmacokinetic data. The plasma levels of LPV were found to increase significantly upon co‐administration with GFJ in single dose as well as multidose pretreatment studies. Similar, but marginally higher, results were observed upon co‐administration of LPV with RTV. No significant change in tmax was observed in the various treatment groups. The apparent permeability of LPV in the ileum increased significantly after the pre‐incubation with GFJ and RTV compared with no pre‐incubation. The GFJ and RTV showed a significant and similar inhibitory effect on rat intestinal microsomes in the metabolism of LPV. The GFJ was equally effective as RTV in increasing the bioavailability of LPV. Copyright © 2012 John Wiley & Sons, Ltd.
Bibliography:istex:F40ECF7792F13601AA707CD6D040FFE298A57D22
ArticleID:PTR4593
ark:/67375/WNG-ZP0DMJXT-2
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0951-418X
1099-1573
DOI:10.1002/ptr.4593